Kerecis was founded by Fertram Sigurjonsson around the concept of using fish skin to heal damaged tissue. The company is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid rich (including Omega3) products from the company's patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring. The Kerecis products are used to regenerate tissue in trauma and chronic wounds such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications. The vision of Kerecis is to extend human life by supporting the body’s own ability to regenerate. The Kerecis mission is to become the world leader in regenerating damage of the human body by sustainably harnessing nature’s own remedies. In August 2023 Kerecis became Iceland’s first Unicorn when it sold to the Danish company Coloplast for $1.3 Billion.